MORPHINE AND METABOLITE BEHAVIOR AFTER DIFFERENT ROUTES OF MORPHINE ADMINISTRATION - DEMONSTRATION OF THE IMPORTANCE OF THE ACTIVE METABOLITE MORPHINE-6-GLUCURONIDE

被引:378
作者
OSBORNE, R
JOEL, S
TREW, D
SLEVIN, M
机构
[1] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND
[2] HOMERTON HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON,ENGLAND
关键词
D O I
10.1038/clpt.1990.2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetic parameters of morphine, morphine-6-glucuronide, and morphine-3-glucuronide were studied after single-dose morphine administration by five different routes. The quantitative significance of the active metabolite morphine-6-glucuronide was assessed, and the effects of novel dosing forms on morphine metabolism and distribution were examined. After administration of intravenous morphine the morphine-6-glucuronide plasma AUC exceeded that of morphine. After administration of oral morphine very low morphine levels were observed-the morphine-6-glucuronide plasma AUC exceeded that of morphine by a factor of 9: 1. Sublingual, buccal, and sustained-release buccal morphine tablet administration resulted in delayed absorption, with attenuation and delay of peak morphine and metabolite levels. Morphine bioavailability and morphine glucuronide production were not altered. © 1990.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 23 条
[1]   PHARMACOKINETICS OF SINGLE-DOSE IV MORPHINE IN NORMAL VOLUNTEERS AND PATIENTS WITH END-STAGE RENAL-FAILURE [J].
AITKENHEAD, AR ;
VATER, M ;
ACHOLA, K ;
COOPER, CMS ;
SMITH, G .
BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (08) :813-819
[2]   INFLUENCE OF PH ON THE BUCCAL ABSORPTION OF MORPHINE-SULFATE AND ITS MAJOR METABOLITE, MORPHINE-3-GLUCURONIDE [J].
ALSAYEDOMAR, O ;
JOHNSTON, A ;
TURNER, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (11) :934-935
[3]  
BELL MDD, 1985, LANCET, V1, P71
[4]  
BRUNK SF, 1974, CLIN PHARMACOL THER, V16, P51
[5]   PATIENT-CONTROLLED ANALGESIC THERAPY .4. PHARMACOKINETICS AND ANALGESIC PLASMA-CONCENTRATIONS OF MORPHINE [J].
DAHLSTROM, B ;
TAMSEN, A ;
PAALZOW, L ;
HARTVIG, P .
CLINICAL PHARMACOKINETICS, 1982, 7 (03) :266-279
[6]   SERUM MORPHINE CONCENTRATIONS AFTER BUCCAL AND INTRAMUSCULAR MORPHINE ADMINISTRATION [J].
FISHER, AP ;
FUNG, C ;
HANNA, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (06) :685-687
[7]   ANALYSIS OF MORPHINE AND ITS MAJOR METABOLITES BY DIFFERENTIAL RADIOIMMUNOASSAY [J].
HAND, CW ;
MOORE, RA ;
MCQUAY, HJ ;
ALLEN, MC ;
SEAR, JW .
ANNALS OF CLINICAL BIOCHEMISTRY, 1987, 24 :153-160
[8]   AN IMPROVED METHOD FOR THE SIMULTANEOUS DETERMINATION OF MORPHINE AND ITS PRINCIPAL GLUCURONIDE METABOLITES [J].
JOEL, SP ;
OSBORNE, RJ ;
SLEVIN, ML .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 430 (02) :394-399
[9]   STRIPE - AN INTERACTIVE COMPUTER-PROGRAM FOR THE ANALYSIS OF DRUG PHARMACOKINETICS [J].
JOHNSTON, A ;
WOOLLARD, RC .
JOURNAL OF PHARMACOLOGICAL METHODS, 1983, 9 (03) :193-199
[10]   CONTROLLED-RELEASE ORAL MORPHINE-SULFATE IN THE TREATMENT OF CANCER PAIN WITH PHARMACOKINETIC CORRELATION [J].
KHOJASTEH, A ;
EVANS, W ;
REYNOLDS, RD ;
THOMAS, G ;
SAVARESE, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :956-961